Comparison of outcomes between metaplastic and triple-negative breast cancer patients. (February 2020)

• Record Type: Journal Article
• Authors: Polamraju, Praveen; Haque, Waqar; Cao, Kevin; Verma, Vivek; Schwartz, Mary; Klimberg, V. Suzanne; Hatch, Sandra; Niravath, Polly; Butler, E. Brian; Teh, Bin S.
• Is Part Of: Breast. Volume 49(2020)
• Page Start: 8
• Page End: 16
• Publication Date: 2020-02
• Subjects: Breast cancer -- Triple-negative -- Metaplastic -- Radiation therapy -- Chemotherapy; Breast -- Diseases -- Periodicals; Breast -- Tumors -- Periodicals; Breast -- Periodicals; Electronic journals; Periodicals; 616
• DOI: 10.1016/j.breast.2019.10.003
• Languages: English
• ISSNs: 0960-9776

Abstract

Abstract: Purpose: Metaplastic breast cancer (MBC) is a rare, aggressive variant of breast cancer that has been associated with poor clinical outcomes, as has triple-negative breast (TNBC) cancer. Limited studies compare the clinical characteristics and prognosis of MBC to TNBC. This study uses a large, contemporary US cancer database to compare clinical characteristics and survival outcomes for patients with MBC to those with TNBC. Methods: The National Cancer Database was queried for women with cT1-4N1-3M0 MBC or TNBC diagnosed between 2004 and 2013 and treated with definitive surgery. Chi-squared analysis was performed to determine differences between the cohorts. Kaplan-Meier curves compared overall survival (OS), and Cox regression determined patient factors associated with OS. Results: Altogether, 55, 847 patients met the inclusion criteria; 50, 705 (90.8%) had TNBC and 5, 142 (9.2%) had MBC. Most patients had no comorbid conditions (82%), N0 disease (71%), poorly differentiated histology (77%), received chemotherapy (87%), and received radiation therapy (60%). Amongst all patients, patients with TNBC disease were observed to have greater OS than those with MBC (5-year OS 72.0% vs 55.8%, p < 0.001). The greater observed OS for patients with TNBC persisted when controlling for stage and when comparing propensity score matched cohorts. On Cox regression, lower age, T1 status, N0 status, chemotherapy, TNBC disease, and radiation therapy (RT) were associated with improved OS. Conclusions: MBC had an association with poorer OS compared to TNBC, while RT and chemotherapy receipt were associated with improved OS for patients regardless of stage. Further studies are needed to corroborate the conclusions herein. Highlights: Metaplastic breast cancer is associated with poor clinical outcomes. Metaplastic breast cancer associated with worse survival than patients with triple negative invasive ductal carcinoma. Radiation therapy and chemotherapy associated with improved survival for patients with metaplastic breast cancer.